Jeff Fairman - May 20, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
Jeff Fairman, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
May 20, 2022
Transactions value $
-$104,856
Form type
4
Date filed
5/24/2022, 04:32 PM
Previous filing
May 9, 2022
Next filing
Aug 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale -$105K -4.11K -1.26% $25.50 321K May 20, 2022 By Fairman Family Trust F1
holding PCVX Common Stock 17.7K May 20, 2022 Direct F2
holding PCVX Common Stock 50K May 20, 2022 By AF 2020 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 1,033 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.